PM&R
Volume 1, Issue 5 , Pages 466-470, May 2009

Emerging Technologies for Degenerative Disk Disease: Potential Synergy Between Biochemical Signaling and Spinal Biomechanics

  • Steven Leckie, MD

      Affiliations

    • Department of Orthopaedic Surgery, Ferguson Laboratory for Orthopaedic Research, University of Pittsburgh, Pittsburgh, PA
  • ,
  • Gwendolyn Sowa, MD, PhD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, University of Pittsburgh, 3471 5th Ave Suite 201, Pittsburgh, PA 15213
    • Corresponding Author InformationAddress correspondence to: G.S.

Received 21 October 2008; accepted 26 February 2009.

Interventional spinal procedures are performed with increasing frequency, and they remain an important tool for physiatrists treating patients with spine pain. As the potential treatment options expand with novel technologies on the horizon, such as gene- and cell-based therapies, the physiatrist will be uniquely poised to deliver such treatments in conjunction with exercise-based therapies. Therefore, the development of novel technologies requires particular attention to the potential synergy between biochemical signaling and spinal biomechanics. It is hoped that such insight will result in improved treatment options for patients with pain related to degenerative disk disease, leading to improved nonoperative outcomes. This article reviews the current knowledge of precipitants of disk degeneration, the effects of beneficial and traumatic levels of disk loading, and how each of these can be impacted by novel treatment options.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  •  Disclosure: nothing to disclose
  •  Disclosure: nothing to disclose

PII: S1934-1482(09)00222-6

doi:10.1016/j.pmrj.2009.02.011

PM&R
Volume 1, Issue 5 , Pages 466-470, May 2009